Cadrenal Therapeutics, Inc. (CVKD) stock
CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.88+0.48 (+34.29%)
Close on Nov 17, 2026Market cap $6.71MP/E –Yield 877.66%
Cadrenal Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Cadrenal Therapeutics's total assets was $5.59M at Jun 30, 2026. For fiscal 2025 it was $4.33M, down 57.3% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.33M | -57.3% |
| FY2024 | Dec 31, 2024 | $10.12M | +18.8% |
| FY2023 | Dec 31, 2023 | $8.52M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.59M | -6.5% |
| Q1 FY2026 | Mar 31, 2026 | $2.86M | -64.0% |
| Q4 FY2025 | Dec 31, 2025 | $4.33M | -57.3% |
| Q3 FY2025 | Sep 30, 2025 | $4.09M | -12.6% |
| Q2 FY2025 | Jun 30, 2025 | $5.98M | +9.6% |
| Q1 FY2025 | Mar 31, 2025 | $7.95M | +12.8% |
| Q4 FY2024 | Dec 31, 2024 | $10.12M | +18.8% |
| Q3 FY2024 | Sep 30, 2024 | $4.68M | -49.7% |
| Q2 FY2024 | Jun 30, 2024 | $5.46M | +21.8% |
| Q1 FY2024 | Mar 31, 2024 | $7.05M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.52M | – |
| Q3 FY2023 | Sep 30, 2023 | $9.31M | – |
| Q1 FY2023 | Mar 31, 2023 | $4.48M | – |
See a number that looks wrong?